GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,507.00p
   
  • Change Today:
      51.00p
  • 52 Week High: 1,766.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,098.64m
  • Volume: 23,131,734
  • Market Cap: £61,766m
  • RiskGrade: 129

Latest Deals

Traded Action Notifier PriceAmountValue
16-May-25 Buy Dividends Hal Barron 2,834.06p 87 £2,465.63
16-May-25 Buy Dividends Hal Barron 2,834.06p 3,449 £97,746.72
12-May-25 Transfer From Julie Brown 0.000p 10 £0.00
12-May-25 Buy Julie Brown 1,350.75p 10 £135.07
12-May-25 Transfer From Emma Walmsley 0.000p 9 £0.00
12-May-25 Buy Emma Walmsley 1,350.75p 9 £121.57
06-May-25 Sell Emma Walmsley 1,448.96p 5,473 £79,301.58
06-May-25 Transfer From Emma Walmsley 0.000p 11,643 £0.00
16-Apr-25 Buy Dividends Julie Brown 1,275.00p 1,588 £20,247.00
16-Apr-25 Buy Dividends Emma Walmsley 1,275.00p 4,930 £62,857.50
11-Apr-25 Buy Vishal Sikka 1,304.95p 196 £2,557.70
11-Apr-25 Buy Jeannie Lee 1,304.95p 20 £260.99
11-Apr-25 Buy Jesse Goodman 1,304.95p 44 £574.18
11-Apr-25 Buy Harry (Hal) C. Dietz 1,304.95p 44 £574.18
11-Apr-25 Buy Anne Beal 1,304.95p 44 £574.18
11-Apr-25 Buy Hal Barron 1,304.95p 58 £756.87
11-Apr-25 Buy Charles Bancroft 1,304.95p 348 £4,541.22
11-Apr-25 Buy Elizabeth (Liz) McKee Anderson 1,304.95p 52 £678.57
10-Apr-25 Buy Dividends Emma Walmsley 1,306.68p 4,560 £59,584.61
09-Apr-25 Transfer From Julie Brown 0.000p 10 £0.00

Latest Notification of Holdings

No notifications of holding were found in the last 365 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,507.00p
Change Today 51.00p
% Change 3.50 %
52 Week High 1,766.50
52 Week Low 1,264.00
Volume 23,131,734
Shares Issued 4,098.64m
Market Cap £61,766m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.42% below the market average45.42% below the market average45.42% below the market average45.42% below the market average45.42% below the market average
26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average
Price Trend
18.04% above the market average18.04% above the market average18.04% above the market average18.04% above the market average18.04% above the market average
43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average
Income
74.28% above the market average74.28% above the market average74.28% above the market average74.28% above the market average74.28% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
36.99% below the market average36.99% below the market average36.99% below the market average36.99% below the market average36.99% below the market average
46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 30-May-2025

Time Volume / Share Price
16:48 42 @ 1,507.00p
16:47 12,890 @ 1,496.62p
16:25 0 @ 1,514.00p
16:24 0 @ 1,513.00p
16:23 2 @ 1,513.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page